Control & symptomatic relief of acute nonspecific diarrhea & chronic diarrhea associated w/ inflammatory bowel disease. Reduction of number & vol of discharge in patients w/ ileostomies & colostomies.
Adult & childn over 12 yrSymptomatic relief of acute diarrhea Initially 2 cap followed by 1 cap after each loose bowel movement. Max: 16 mg daily (8 cap). Discontinue use if there is no improvement after 2 days. Symptomatic relief of chronic diarrhea Initially 2 cap followed by 1 cap after each loose bowel movement, then reduce dose to meet individual requirements. When optimal daily dose has been established, administer as a single dose or in divided doses. Ave daily maintenance dose: 2-4 cap daily. If no clinical improvement is observed after treatment w/ 8 cap daily (16 mg daily) for at least 10 days, symptoms are unlikely to be controlled.
Hypersensitivity. Constipation, swollen abdomen or abdominal pain, acute dysentery characterized by blood in stools & high fever; pseudomembranous colitis, active ulcerative colitis, meningitis or history of liver disease. Pregnancy & lactation. Childn <12 yr.
Appropriate fluid & electrolyte intake. Patients w/ AIDS should stop therapy at the earliest signs of abdominal distention. Toxic megacolon in AIDS pateints w/ infectious colitis. Loss/depressed level of consciousness, tiredness, dizziness, or drowsiness may occur. Avoid alcohol or milk, fruits, green vegetables, & spicy or fatty foods. Childn.
Sign Out
